EP2485789A1 — Drug delivery device with clearance compensation means
Assigned to Sanofi Aventis Deutschland GmbH · Expires 2012-08-15 · 14y expired
What this patent protects
The present invention relates to a drug delivery device for dispensing of a predefined dose of a medicinal product, comprising: a housing (14), a cartridge holder (16) adapted to receive a cartridge (18) containing the medicinal product to be dispensed, the cartridge holder (16) …
USPTO Abstract
The present invention relates to a drug delivery device for dispensing of a predefined dose of a medicinal product, comprising: a housing (14), a cartridge holder (16) adapted to receive a cartridge (18) containing the medicinal product to be dispensed, the cartridge holder (16) being connectable to the housing (14), a drive mechanism (12) to be operably engaged with the cartridge (18) for setting and/or dispensing of a predefined dose of the medicinal product, wherein the drive mechanism (12) is axially slidingly supported in the housing (14) for compensating axial clearance between the drive mechanism (12) and the cartridge (18) and wherein the drive mechanism (12) is axially fixable relative to the housing (14).
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.